This company has shut down. Praetego is no longer operating — its last tracked round was a Grant in 2023.
Explore the Startup GraveyardPraetego is a pharmaceutical company focused on addressing serious diabetic complications.
Praetego has raised $300K in total funding. The most recent round was Grant. The last funding was announced in March 2023.
Praetego's investors include Stony Lonesome Group, National Institute on Aging, National Eye Institute, National Institute of Diabetes and Digestive and Kidney Diseases.
Praetego is headquartered in Durham, United States.
Praetego is a pharmaceutical company focused on addressing serious diabetic complications.
Praetego is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Praetego — Funding & Investors." VCBacked, March 1, 2023, https://www.vcbacked.co/company/praetego. Accessed September 30, 2026.
VCBacked. (2023). Praetego — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/praetego
{{cite web |title=Praetego — Funding & Investors |url=https://www.vcbacked.co/company/praetego |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated